Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jun 4;16(1):78.
doi: 10.1186/s12916-018-1073-z.

Measuring and mapping the global burden of antimicrobial resistance

Simon I Hay  1   2 , Puja C Rao  1 , Christiane Dolecek  3   4 , Nicholas P J Day  3   4 , Andy Stergachis  5 , Alan D Lopez  6   7 , Christopher J L Murray  1
Affiliations

Measuring and mapping the global burden of antimicrobial resistance

Simon I Hay et al. BMC Med. .

Abstract

The increasing number and global distribution of pathogens resistant to antimicrobial drugs is potentially one of the greatest threats to global health, leading to health crises arising from infections that were once easy to treat. Infections resistant to antimicrobial treatment frequently result in longer hospital stays, higher medical costs, and increased mortality. Despite the long-standing recognition of antimicrobial resistance (AMR) across many settings, there is surprisingly poor information about its geographical distribution over time and trends in its population prevalence and incidence. This makes reliable assessments of the health burden attributable to AMR difficult, weakening the evidence base to drive forward research and policy agendas to combat AMR. The inclusion of mortality and morbidity data related to drug-resistant infections into the annual Global Burden of Disease Study should help fill this policy void.

Keywords: Anti-infective agents; Antimicrobial drugs; Antimicrobial resistance; Drug-resistant infections; Global burden of disease; Global health; Microbial; Public health.

PubMed Disclaimer

Conflict of interest statement

Competing interests

The authors declare that they have no competing interest.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

    1. Chief Medical Officer Annual Report 2011. Antimicrobial Resistance - GOV.UK. https://www.gov.uk/government/publications/chief-medical-officer-annual-.... Accessed 19 Mar 2018.
    1. Shallcross LJ, Howard SJ, Fowler T, Davies SC. Tackling the threat of antimicrobial resistance: from policy to sustainable action. Philos Trans R Soc Lond Ser B Biol Sci. 2015;370:20140082. doi: 10.1098/rstb.2014.0082. - DOI - PMC - PubMed
    1. World Health Organization. Antimicrobial Resistance: Global Report on Surveillance 2014. http://www.who.int/drugresistance/documents/surveillancereport/en/. Accessed 20 Mar 2018.
    1. Mladenovic-Antic S, Kocic B, Velickovic-Radovanovic R, Dinic M, Petrovic J, Randjelovic G, et al. Correlation between antimicrobial consumption and antimicrobial resistance of Pseudomonas aeruginosa in a hospital setting: a 10-year study. J Clin Pharm Ther. 2016;41:532–537. doi: 10.1111/jcpt.12432. - DOI - PubMed
    1. Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA. 1997;278:901–904. doi: 10.1001/jama.1997.03550110039033. - DOI - PubMed

Publication types

MeSH terms

Substances